title: Effects of avian triggering receptor expressed on myeloid cells (TREM-A1) activation on heterophil functional activities.
abstract: A class of innate receptors called the triggering receptors expressed on myeloid cells (TREM) has been discovered and shown to be involved in innate inflammatory responses. The TREM family has been found in the chicken genome and consists of one activating gene (TREM-A1) and two inhibitory genes (TREM-B1 and TREM-B2). However, to date, there have been no reports on the effects of activating the TREM molecules on the functional activity of the primary avian polymorphonuclear cell, the heterophil. To characterize the activation of avian heterophils, we evaluated the effect of receptor ligation on heterophil effector functions. A specific agonistic antibody (Ab) was generated against the peptide sequence of chicken TREM-A1 38-51aa (YNPRQQRWREKSWC). To study TREM-A1 mediated activation, purified peripheral blood heterophils were incubated with various concentrations of the anti-TREM-A1 Ab or control Ab against an irrelevant antigen. Activation via TREM-A1 induces a significant increase in phagocytosis of Salmonella enteritidis, a rapid degranulation, and a dramatic up-regulation in gene expression of the pro-inflammatory cytokine, IL-6, and the inflammatory chemokine, CXCLi2. However, we found no direct TREM-A1 stimulation of the heterophil oxidative burst. Like mammalian TREM, avian TREM-A1 ligation synergizes with the activation of Toll-like receptor-4 (TLR4) ligand, LPS. In addition, the synergistic activity of LPS and TREM-A1 resulted in a significantly (p⩽0.05) increased production of an oxidative burst. Taken together, these results suggest, unlike in mammalian neutrophils, TREM-A1 engagement activates a differential functional activation of avian heterophils, but like mammalian neutrophils, acts in synergy with TLR agonists. These results provide evidence of the function of TREM-A1 in heterophil biology and avian innate immunity.
authors.affiliation: Developmental and Comparative Immunology, SPARC, USDA-ARS, College Station, TX 77845, USA. kogut@ffsru.tamu.edu
authors.forename: M H
authors.initials: MH
authors.lastname: Kogut
authors.forename: K J
authors.initials: KJ
authors.lastname: Genovese
authors.forename: J R
authors.initials: JR
authors.lastname: Nerren
authors.forename: H
authors.initials: H
authors.lastname: He
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D015550:Cell Degranulation / Q000187:drug effects; D054377:Chemokine CXCL12 / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D002645:Chickens; D007113:Immunity, Innate; D007249:Inflammation; D015850:Interleukin-6 / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D010446:Peptide Fragments / Q000819:agonists / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects; D011971:Receptors, Immunologic / Q000819:agonists / Q000276:immunology; D012480:Salmonella Infections / Q000276:immunology*; D012477:Salmonella enteritidis / Q000276:immunology* / Q000472:pathogenicity; D051197:Toll-Like Receptor 4 / Q000819:agonists; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D054377:Chemokine CXCL12; D015850:Interleukin-6; D008070:Lipopolysaccharides; D010446:Peptide Fragments; D011971:Receptors, Immunologic; D051197:Toll-Like Receptor 4